These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32015474)

  • 1. Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine.
    Modvig IM; Andersen DB; Grunddal KV; Kuhre RE; Martinussen C; Christiansen CB; Ørskov C; Larraufie P; Kay RG; Reimann F; Gribble FM; Hartmann B; Bojsen-Møller KN; Madsbad S; Wewer Albrechtsen NJ; Holst JJ
    Int J Obes (Lond); 2020 Sep; 44(9):1859-1871. PubMed ID: 32015474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.
    Sterl K; Wang S; Oestricker L; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
    Peptides; 2016 Aug; 82():76-84. PubMed ID: 27288245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass Surgery.
    Jorsal T; Wewer Albrechtsen NJ; Christensen MM; Mortensen B; Wandall E; Langholz E; Friis S; Worm D; Ørskov C; Støving RK; Andries A; Juhl CB; Sørensen F; Forman JL; Falkenhahn M; Musholt PB; Theis S; Larsen PJ; Holst JJ; Vrang N; Jelsing J; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6403-6416. PubMed ID: 31276156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
    Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
    Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
    Svane MS; Bojsen-Møller KN; Martinussen C; Dirksen C; Madsen JL; Reitelseder S; Holm L; Rehfeld JF; Kristiansen VB; van Hall G; Holst JJ; Madsbad S
    Gastroenterology; 2019 May; 156(6):1627-1641.e1. PubMed ID: 30742833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
    Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
    Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats.
    Camacho-Ramírez A; Prada-Oliveira JA; Ribelles-García A; Almorza-Gomar D; Pérez-Arana GM
    Obes Surg; 2020 Feb; 30(2):697-706. PubMed ID: 31701411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery.
    Pal A; Rhoads DB; Tavakkoli A
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G668-G678. PubMed ID: 30896970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
    Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study.
    Miras AD; Kamocka A; Pérez-Pevida B; Purkayastha S; Moorthy K; Patel A; Chahal H; Frost G; Bassett P; Castagnetto-Gissey L; Coppin L; Jackson N; Umpleby AM; Bloom SR; Tan T; Ahmed AR; Rubino F
    Diabetes Care; 2021 May; 44(5):1082-1090. PubMed ID: 33158945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
    Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet.
    Wallenius V; Elias E; Elebring E; Haisma B; Casselbrant A; Larraufie P; Spak E; Reimann F; le Roux CW; Docherty NG; Gribble FM; Fändriks L
    Gut; 2020 Aug; 69(8):1423-1431. PubMed ID: 31753852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery.
    Oh TJ; Ahn CH; Cho YM
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):94-101. PubMed ID: 27186363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.
    Rubino F; Forgione A; Cummings DE; Vix M; Gnuli D; Mingrone G; Castagneto M; Marescaux J
    Ann Surg; 2006 Nov; 244(5):741-9. PubMed ID: 17060767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preprohormone expression profile of enteroendocrine cells following Roux-en-Y gastric bypass in rats.
    Zhang C; Rigbolt K; Petersen SL; Biehl Rudkjær LC; Schwahn U; Fernandez-Cachon ML; Bossart M; Falkenhahn M; Theis S; Hübschle T; Schmidt T; Just Larsen P; Vrang N; Jelsing J
    Peptides; 2019 Aug; 118():170100. PubMed ID: 31212005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.
    Mumphrey MB; Patterson LM; Zheng H; Berthoud HR
    Neurogastroenterol Motil; 2013 Jan; 25(1):e70-9. PubMed ID: 23095091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control.
    Fernandez-Cachon ML; Pedersen SL; Rigbolt KT; Zhang C; Fabricius K; Hansen HH; Elster L; Fink LN; Schäfer M; Rhee NA; Langholz E; Wandall E; Friis SU; Vilmann P; Kristiansen VB; Schmidt C; Schreiter K; Breitschopf K; Hübschle T; Jorsal T; Vilsbøll T; Schmidt T; Theis S; Knop FK; Larsen PJ; Jelsing J
    Peptides; 2018 Mar; 101():32-43. PubMed ID: 29289697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.